ClassID:

93392

C07C309/68 - CPC Classification

Classification description:

Sulfonic acids; Halides, esters, or anhydrides thereof; Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a carbon skeleton substituted by singly-bound oxygen atoms

Recent Application in this class:
#1
20230167053
2023-06-01

Methane-production inhibitor composition and method for inhibiting methane production

#2
20230159439
2023-05-25

ARYLAMIDES AND METHODS OF USE THEREOF

#3
20230021429
2023-01-26

BASE-LABILE PROTECTING GROUPS FOR STEPWISE POLYMER SYNTHESIS

#4
20220304929
2022-09-29

LIPIDS FOR DELIVERY OF CHARGED MATERIAL, FORMULATIONS THEREOF AND METHOD FOR MAKING SAME

#5
20220098137
2022-03-31

ARYL COMPOUNDS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME

#6
20200331831
2020-10-22

Aryl compounds and polymers and methods of making and using the same

#7
20200231749
2020-07-23

Polyethylene glycol derivative and preparation method thereof

#8
20190225596
2019-07-25

Cannabinergic nitrate esters and related analogs

#9
20190192474
2019-06-27

Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Skin Cancer

#10
20190192473
2019-06-27

Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Rosacea

#11
20180244596
2018-08-30

Aryl compounds and polymers and methods of making and using the same

#12
20180046077
2018-02-15

Fluorinated sulfonate esters of aryl ketones for non-ionic photo-acid generators

#13
20180044459
2018-02-15

Non-ionic aryl ketone based polymeric photo-acid generators

#14
20180028484
2018-02-01

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of glioma

#15
20170233337
2017-08-17

Non-ionic amphiphiles and methods of making the same

#16
20170210728
2017-07-27

Cannabinergic nitrate esters and related analogs

#17
20170065547
2017-03-09

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer

#18
20160355497
2016-12-08

Thiopyranose compound and method for producing same

#19
20160002195
2016-01-07

Cannabinergic nitrate esters and related analogs

#20
20150367307
2015-12-24

Anionic surfactant compositions and use thereof

#21
20150224462
2015-08-13

Anionic surfactant compositions and use thereof

#22
20150141476
2015-05-21

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea

#23
20140328823
2014-11-06

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer

#24
20140296523
2014-10-02

Ionic liquids, the method for preparing the same and method for removing acetylenes from olefin mixtures using the ionic liquids

#25
20140206654
2014-07-24

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ

#26
20140018330
2014-01-16

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea

#27
20130101895
2013-04-25

Electrolyte solution for a secondary battery

#28
20120322769
2012-12-20

Methods of reducing virulence in bacteria

#29
20120184763
2012-07-19

METHOD FOR PRODUCING PERFLUOROSULFONIC ACID HAVING ETHER STRUCTURE AND DERIVATIVE THEREOF, AND SURFACTANT CONTAINING FLUORINE-CONTAINING ETHER SULFONIC ACID COMPOUND AND DERIVATIVE THEREOF

#30
20120087904
2012-04-12

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer

#31
20120083642
2012-04-05

Ionic liquids, the method for preparing the same and method for removing acetylenes from olefin mixtures using the ionic liquids

#32
20120034517
2012-02-09

Secondary battery using an electrolyte solution

#33
20110311528
2011-12-22

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of psoriasis

#34
20110237555
2011-09-29

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea

#35
20090306016
2009-12-10

Fatty acid amide hydrolase inhibitors

#36
20090291390
2009-11-26

Acid generating agent for chemically amplified resist compositions

#37
20080125486
2008-05-29

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ

#38
20080114183
2008-05-15

Monomers comprising superacidic groups, and polymers therefrom

#39
20080114060
2008-05-15

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer

#40
20080113948
2008-05-15

Use of 2,5-Dihydroxybenzene Compounds and Derivatives for the Treatment of Psoriasis

#41
20080113947
2008-05-15

Use of 2,5-Dihydroxybenzene Compounds and Derivatives for the Treatment of Rosacea

#42
20060292452
2006-12-28

Additive for an electrolyte solution for an electrochemical device

#43
20060039855
2006-02-23

Solid phase preparation of F-labelled amino acids

#44
20050038259
2005-02-17

Hydroxyeicosenoic acid anaglogs

#45
20050020680
2005-01-27

Hydroxyfattysulfonic acid analogs